UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000003448
Receipt No. R000004172
Official scientific title of the study Effects of Helicobacter pylori eradication therapy on ulcer healing after gastric endoscopic submucosal dissection: a prospective randomized controlled trial.
Date of disclosure of the study information 2010/04/06
Last modified on 2016/04/05 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of Helicobacter pylori eradication therapy on ulcer healing after gastric endoscopic submucosal dissection: a prospective randomized controlled trial.
Title of the study (Brief title) Effects of eradication on gastric ESD
Region
Japan

Condition
Condition Gastric cancer and gastric adenoma
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the benefit of H. pylori eradication before ESD to promote ulcer healing after the procedure.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes state of ulcer healing on 28 days
Key secondary outcomes bleeding after ESD

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit
Blinding Open -but assessor(s) are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Helicobacter pylori eradication before gastric ESD
PPI-based triple therapy consisting of lansoprazole (60 mg), amoxicillin (1500 mg) and clarithromycin (400 mg)
Interventions/Control_2 Helicobacter pylori eradication after gastric ESD
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Helicobacter pylori positive-patients with gastric cancer or gastric adenoma

1. Not less than 20 years old (no upper limit)
2.Written informed consent
Key exclusion criteria 1)using PPIs and H2RAs
2)using anti-coagulants
3)allergy to drugs
4)severe liver dysfunction
5)severe renal dysfunction
6)Pregnant or lactating women or women
Target sample size 150

Research contact person
Name of lead principal investigator Shouko Ono
Organization Hokkaido University Hospital
Division name Division of Endoscopy
Address Kita-14, Nishi-5, Kita-ku, Sapporo, Japan
TEL 011-716-1161
Email onosho@med.hokudai.ac.jp

Public contact
Name of contact person Shouko Ono
Organization Hokkaido University Hospital
Division name Division of Endoscopy
Address N-14, W-5, Kita-ku, Sapporo
TEL 011-716-1161(5723)
Homepage URL
Email onosho@med.hokudai.ac.jp

Sponsor
Institute Division of Endoscopy, Hokkaido University Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 北海道大学病院 

Other administrative information
Date of disclosure of the study information
2010 Year 04 Month 06 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2009 Year 09 Month 03 Day
Anticipated trial start date
2009 Year 10 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2010 Year 04 Month 05 Day
Last modified on
2016 Year 04 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/icdr_e/ctr_view.cgi?recptno=R000004172